tucatinib January 19, 2018 tucatinib Trade Name Orphan Indication HER2+ colorectal cancer USA Market Approval USA USA Designation Date 2017-09-18 00:00:00 Sponsor Cascadian Therapeutics, Inc.;2601 4th Avenue, Suite 500;Seattle, Washington, 98121
